What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Cancer Diagnostics
AI Against Cancer: Capabilities and Limitations for Early Detection and Treatment Planning
The American Cancer Society predicted 2 million new cancer cases in the US alone in 2024, which amounts to roughly 5,480 diagnoses every day. What makes matters worse is that the pandemic delayed care for more than 75% of cancer patients. Unsurprisingly, healthcare providers are turning to new technologies like AI in search of solutions. To gauge the magnitude of this trend, consider this: as of August 7, 2024, 950 AI/ML-enabled medical devices have received clearance from the FDA, with 76% of
Read More
miRoncol Develops Multi-Cancer Early Detection Blood Test
What You Should Know:
- miRoncol, a medtech startup, has announced the completion of proof-of-concept studies for a groundbreaking multi-cancer early detection blood test.
- The test utilizes microRNA analysis and machine learning, two technologies recognized by the 2024 Nobel Prizes, to identify cancers at their earliest stages, even before the onset of noticeable symptoms.
The Power of microRNA and Machine Learning
MicroRNAs (miRNAs) are small RNA molecules that play a
Read More
MedCognetics Unveils Embedded AI Cancer Detection System for Mammography Imaging
What You Should Know:
- MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI image processing and cancer detection system for mammography.
- The system utilizes the NVIDIA IGX OrinTM medical-grade edge AI platform alongside MedCognetics’ advanced AI-enabled software, CogNet AI-MT, which was developed in collaboration with clinical leaders worldwide. CogNet AI-MT has been trained on a diverse
Read More
Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data
What You Should Know:
- Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD).
- Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality
Read More
Morehouse School of Medicine Tackles Cancer Disparities with AI-Driven Research
What You Should Know:
- Manifold, an AI-powered clinical data platform, announced that Morehouse School of Medicine (MSM) will leverage their platform to modernize cancer genomics data analysis and improve collaboration among multidisciplinary stakeholders.
- With Manifold, the Institute of Translational Genomic Medicine (ITGM) at MSM is building a modern data foundation to accelerate cancer research—integrating multimodal sources like clinical outcomes, genomics, survey, and geospatial
Read More
Panalgo Partners with COTA to Enhance AI & RWD-Enabled Cancer Care
What You Should Know:
- Panalgo, a provider of healthcare data analytics solutions, has announced a partnership with COTA, an organization focused on providing real-world data (RWD) for cancer care.
- The strategic collaboration will enable COTA to make its high-quality hematologic oncology data available through Panalgo's Instant Health Data Analytics (IHD) platform.
Leveraging COTA's Real-World Data
COTA's RWD is derived from electronic health records (EHRs) and offers
Read More
CancerIQ Raises Growth Capital for Personalized Cancer Detection
What You Should Know:
- CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital Partners.
- While specific financial details of the transaction were not disclosed, the investment will enable CancerIQ to further develop its digital tools, introduce new offerings, and strengthen partnerships with healthcare
Read More
PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments
What You Should Know:
- PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital Venture, and existing investors. This brings the company's total funding to date to $31.5M.
- The new funding will enable PreciseDx to accelerate its growth and expand its operations. The company plans to invest in talent
Read More
Pangea Biomed Partners with Hadassah to Develop Cancer Treatment
What You Should Know:
- Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute (HCRI) at the Hadassah University Hospital Ein-Kerem and Ultima Genomics, the developer of a revolutionary architecture for high-throughput genomic sequencing.
- This partnership aims to enhance the accuracy and effectiveness of solid tumor cancer
Read More
